-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IQUGW74FA7OukhUb5c80BJ+Wsc8CdU7D6/Cx2Fk59QfXpQeDjBxSaHpq1yV4fk+d VY2uE3mHS8cfDIzJOfRtfA== 0001209191-07-039305.txt : 20070628 0001209191-07-039305.hdr.sgml : 20070628 20070628170855 ACCESSION NUMBER: 0001209191-07-039305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070626 FILED AS OF DATE: 20070628 DATE AS OF CHANGE: 20070628 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVERIS CORP CENTRAL INDEX KEY: 0001264899 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 800076765 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 16020 INDUSTRIAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20877 BUSINESS PHONE: 3018699800 MAIL ADDRESS: STREET 1: 16020 INDUSTRIAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20877 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: QUINN JOHN E CENTRAL INDEX KEY: 0001210461 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50583 FILM NUMBER: 07947647 MAIL ADDRESS: STREET 1: C/O POLYONE CORP STREET 2: 200 PUBLIC SQUARE SUITE 36-5000 CITY: CLEVELAND STATE: OH ZIP: 44114-2304 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2007-06-26 1 0001264899 BIOVERIS CORP BIOV 0001210461 QUINN JOHN E C/O BIOVERIS CORPORATION, 16020 INDUSTRIAL DRIVE GAITHERSBURG MD 20877 1 0 0 0 Common Stock 2007-06-26 4 D 0 4661 21.50 D 0 D Stock Option (Right to Buy) 8.42 2007-06-26 4 D 0 16000 D 2007-06-26 Common Stock 16000 0 D Disposed of pursuant to the Agreement and Plan of Merger ("merger agreement"), dated as of April 4, 2007, among the Issuer, Roche Holding Ltd and Lili Acquisition Corporation, in exchange for the right to receive $21.50 in cash, without interest, per share of Common Stock of the Issuer held by the reporting person. The amount set forth in the "Conversion or Exercise Price of Derivative Security" column is calculated based upon the average exercise price per share of the options outstanding held by the reporting person. These options were cancelled pursuant to the merger agreement in exchange for the right to receive a cash payment equal to the product of the number of shares subject to such option multiplied by the excess, if any, of (a) $21.50 per share over (b) the exercise price of such option. All options expire after June 26, 2007. /s/ John E. Quinn 2007-06-26 -----END PRIVACY-ENHANCED MESSAGE-----